Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States.
Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States.
复制标题
DOI：
10.1097/adm.0000000000000792
复制
发表时间：
2021-11-01
影响因子：
5.5
通讯作者：
Krans EE
中科院分区：
文献类型：
--
作者：
Jarlenski M;Krans EE
Substance use in pregnancy is increasing in the U.S., although little is know about co-occurring substance use disorders in pregnancy. Our objective was to determine the prevalence and patterns of co-occurring substance use disorders identified at delivery hospitalizations among U.S. women. Using data from the National Inpatient Sample, a nationally representative sample of hospitalizations in the U.S., we identified females ages 15-44 years with a delivery hospitalization from 2007-2016 (weighted N=38 million). We identified diagnoses for use of any of the following substance use disorders: alcohol, amphetamines, cannabis, cocaine, opioids, sedatives, or tobacco. Using multivariable regression, we calculated the weighted adjusted prevalence of additional substances used within each specific substance use disorder category. Seven percent of women were diagnosed with any substance use disorder at delivery hospitalization (6.5% tobacco, 1% cannabis, 0.5% opioids, and <1% had amphetamine, alcohol, cocaine, and sedative). Among those with any substance use disorder diagnosis, the adjusted prevalence of any polysubstance use was greatest for those who used alcohol (69%), cocaine (69%), amphetamines (63%), and opioids (62%). Among pregnant women who were diagnosed with cocaine, amphetamines, alcohol or opioid use disorder, tobacco (>45% in all groups) and cannabis (>10% in all groups) were the most common additional substances used. Tobacco and cannabis use disorders were commonly diagnosed together. Co-occurring substance use disorders are common among women with any substance use disorder in pregnancy. Findings support the need for public health efforts to monitor and address multiple, concurrent use of substances in pregnancy.
